Boehringer Ingelheim and SBP Group partner on six ADC and T-cell engager programmes, with potential milestone payments of up ...
Lupin launches Raltegravir 600 mg tablets in the US after FDA approval, with eligibility for 180-day generic e.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results